|
Neoplasia
Citations 161-170 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib
- Addolorata Maria Luce Coluccia, Teresa Cirulli, Paola Neri, Domenica Mangieri, Maria Cristina Colanardi, Antonio Gnoni, Nicola Di Renzo, Franco Dammacco, Pierfrancesco Tassone, Domenico Ribatti, Carlo Gambacorti-Passerini, and Angelo Vacca
Blood 2008; 112: 1346-1356.
[Abstract]
[Full text]
[PDF]
Inactivating Icmt ameliorates K-RAS–induced myeloproliferative disease
- Annika M. Wahlstrom, Briony A. Cutts, Meng Liu, Annika Lindskog, Christin Karlsson, Anna-Karin M. Sjogren, Karin M. E. Andersson, Stephen G. Young, and Martin O. Bergo
Blood 2008; 112: 1357-1365.
[Abstract]
[Full text]
[PDF]
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
- Heike Kroeger, Jaroslav Jelinek, Marcos R. H. Estécio, Rong He, Kimie Kondo, Woonbok Chung, Li Zhang, Lanlan Shen, Hagop M. Kantarjian, Carlos E. Bueso-Ramos, and Jean-Pierre J. Issa
Blood 2008; 112: 1366-1373.
[Abstract]
[Full text]
[PDF]
Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials
- Wolfram Klapper, Monika Szczepanowski, Birgit Burkhardt, Hilmar Berger, Maciej Rosolowski, Stefan Bentink, Carsten Schwaenen, Swen Wessendorf, Rainer Spang, Peter Möller, Martin Leo Hansmann, Heinz-Wolfram Bernd, German Ott, Michael Hummel, Harald Stein, Markus Loeffler, Lorenz Trümper, Martin Zimmermann, Alfred Reiter, and Reiner Siebert, for the "Molecular Mechanisms in Malignant Lymphomas" Network Project of the Deutsche Krebshilfe
Blood 2008; 112: 1374-1381.
[Abstract]
[Full text]
[PDF]
A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
- Steven W. Paugh, Barbara S. Paugh, Mohamed Rahmani, Dmitri Kapitonov, Jorge A. Almenara, Tomasz Kordula, Sheldon Milstien, Jeffrey K. Adams, Robert E. Zipkin, Steven Grant, and Sarah Spiegel
Blood 2008; 112: 1382-1391.
[Abstract]
[Full text]
[PDF]
t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
- Akiko J. Okumura, Luke F. Peterson, Fumihiko Okumura, Anita Boyapati, and Dong-Er Zhang
Blood 2008; 112: 1392-1401.
[Abstract]
[Full text]
[PDF]
JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
- Isabelle Plo, Mayuka Nakatake, Laurent Malivert, Jean-Pierre de Villartay, Stéphane Giraudier, Jean-Luc Villeval, Lisa Wiesmuller, and William Vainchenker
Blood 2008; 112: 1402-1412.
[Abstract]
[Full text]
[PDF]
Up-regulation of WRN and DNA ligase III in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks
- Annahita Sallmyr, Alan E. Tomkinson, and Feyruz V. Rassool
Blood 2008; 112: 1413-1423.
[Abstract]
[Full text]
[PDF]
Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines
- Daniela Buglio, Georgios V. Georgakis, Shino Hanabuchi, Kazuhiko Arima, Noor M. Khaskhely, Yong-Jun Liu, and Anas Younes
Blood 2008; 112: 1424-1433.
[Abstract]
[Full text]
[PDF]
Quantitative trait loci associated with susceptibility to therapy-related acute murine promyelocytic leukemia in hCG-PML/RARA transgenic mice
- Ryan K. Funk, Taylor J. Maxwell, Masayo Izumi, Deepa Edwin, Friederike Kreisel, Timothy J. Ley, James M. Cheverud, and Timothy A. Graubert
Blood 2008; 112: 1434-1442.
[Abstract]
[Full text]
[PDF]
|
|
